| Record ID | marc_university_of_toronto/uoft.marc:3565622283:1055 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:3565622283:1055?format=raw |
LEADER: 01055cam 2200241 a 4500
005 20001101085047.1
008 001101s2000 ne a b 101 0 eng
020 $a0444503161 (alk. paper)
042 $apcc
050 4 $aQH438.4.B55$bB556 2000
090 08 $aQH 438.4 .B55B556 2000$bGERSTM$c1
245 00 $aBiomarkers and surrogate endpoints :$bclinical research and applications : proceedings of the NIH-FDA conference held on 15-16 April 1999 in Bethesda, Maryland, USA /$cedited by Gregory J. Downing.
250 $a1st ed.
260 $aAmsterdam ;$aNew York :$bElsevier,$c2000.
300 $axxvii, 318 p. :$bill. ;$c25 cm.
440 0 $aInternational congress series ;$vno. 1205
650 0 $aBiochemical Markers$vCongresses.
700 1 $aDowning, Gregory J.
710 2 $aNational Institutes of Health (U.S.)
710 2 $aUnited States.$bFood and Drug Administration.
948 $a11/02/2000$b07/07/2002
039 $fmb/mb(mb)
949 $aQH438.4 .B55 B556 2000$wLC$c1$i31761052889987$d17/6/2004$e25/5/2004$lSTACKS$mGERSTEIN$n6$q1$rY$sY$tBOOK$u6/11/2000